Secret safety warnings on medicines: a case study of information access requests - Torka M, Mintzes B, Bhasale A, Fabbri A, Perry L, Lexchin J.

PURPOSE: There has been less attention to the transparency of postmarket evidence of harmful effects of medicines than of premarket clinical trial data. This is a case study of requests for Australian "direct health professional communications" (DHPCs). Th...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news